Compare DexCom, Inc. (DXCM) vs United States Oil ETF (USO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs United States Oil ETF — how do they compare? DexCom, Inc. trades at $84.11 (market cap $31.86B), while United States Oil ETF trades at $148.2 (market cap $1.90B). The key difference: DexCom, Inc. is far larger — about 16.8× United States Oil ETF's market cap, and United States Oil ETF is more actively traded (5,932,922 versus 3,607,070). Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and United States Oil ETF for 21 Days on average.
| DXCM | USO | |
|---|---|---|
Market Cap | $31.86B | $1.90B |
Volume | 3,607,070 | 5,932,922 |
Sector | Health | — |
52-Week High | $92.34 | $161.86 |
52-Week Low | $54.84 | $66.17 |
Typical Hold Time | 62 Days | 21 Days |
Enterprise Value | $31.32B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $84.41, showing modest daily gains of 0.13%. The stock demonstrates strong fundamental performance with consistent earnings beats and robust revenue growth, reaching $4.66 billion in 2025. Technical indicators show a bearish short-term trend with key support at $82. The company maintains impressive profitability with 20.12% net margins and 38.49% ROE, supported by growing adoption of CGM technology in diabetes care.
DXCM presents a compelling growth story with expanding market opportunities in Type 2 diabetes care. Analyst consensus remains strongly bullish with 81% buy ratings and $95.07 price target, suggesting 13% upside. Key risks include reimbursement challenges and competitive pressures. The company's strong cash flow generation and institutional support provide solid foundation for continued growth.
USO shows strong momentum with a 2.98% gain to $148.20, supported by bullish technical signals including positive moving averages and key resistance at $150. The oil sector faces mixed fundamentals with OPEC+ maintaining steady output while geopolitical tensions in the Middle East create supply uncertainty. Recent news highlights attacks on oil infrastructure and G-7 reserve releases impacting global oil markets.
The stock presents upside potential toward $152-154 resistance levels, though risks include oil price volatility from geopolitical events and potential supply disruptions. Investor sentiment remains cautiously optimistic given the technical strength, but fundamental clarity on earnings and margins is needed for sustained growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About United States Oil ETF
This ETF invests primarily in futures contracts for light, sweet crude oil, other types of crude oil, diesel-heating oil, gasoline, natural gas, and other petroleum-based fuels.
Read more on USO →
